MIST
HealthcareMilestone Pharmaceuticals Inc.
$2.02
$-0.03 (-1.46%)
Jan 5, 2026
Price History (1Y)
Analysis
Milestone Pharmaceuticals Inc. is a healthcare company operating in the biotechnology industry. With a market capitalization of $172.04 million, it has a relatively small scale compared to larger companies. The company employs 33 individuals. The company's financial health is marked by significant losses, with a net income of -$58,012,000 and an EBITDA of -$57,125,000 over the trailing twelve months. This has resulted in negative profitability margins, including a gross margin, operating margin, and profit margin of 0.0%. The company's returns on equity and assets are also negative, standing at -260.7% and -42.0%, respectively. Milestone Pharmaceuticals' balance sheet shows $57.21 million in debt and $82.58 million in cash. The company's valuation is characterized by a P/E ratio of -3.39, indicating significant losses relative to its market capitalization. The forward P/E ratio is also negative at -3.39. The price-to-book ratio stands at 10.00, while the EV/EBITDA ratio is -3.20.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Visit website →Key Statistics
- Market Cap
- $172.04M
- P/E Ratio
- N/A
- 52-Week High
- $3.06
- 52-Week Low
- $0.63
- Avg Volume
- 4.85M
- Beta
- 0.44
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- Canada
- Employees
- 33